Navigation Links
Strawberry fields ripe for the picking
Date:12/6/2007

COLLEGE PARK, MD -- Many fruit farmers in the United States rely heavily on "pick-your-own" (PYO) operations to realize profits and create repeat business. Pick-your-own fruit farms are an important market segment, and consumer satisfaction with the experience is critical to farmers eager to increase seasonal revenues.

A team of researchers from the University of Maryland, Utah State University, and the U.S. Department of Agriculture compared three different strawberry production systems over a two-year period (2003-2004) to determine which system was preferred by consumers who frequented pick-your-own farms. Researchers also examined each production system to compare the quality of strawberries produced and attempted to determine how consumer preference affected the price customers would pay for fresh berries.

Matthew Stevens, a graduate student at the University of Maryland, undertook the research project as part of his Master's thesis. Stevens reported that consumers surveyed in the first year of his study preferred picking fruit from the cold-climate "plasticulture" system. Plasticulture strawberries are grown on raised beds using black plastic mulch and a trickle irrigation system. Farmers use plasticulture because it can extend the growing season and improve crop health and growth. Interestingly, Stevens' team found that consumers surveyed during the second year of the study preferred PYO strawberries grown in the "advanced matted row" system, which features raised beds covered with a cover crop mulch instead of plastic mulch and a subsurface drip irrigation system.

"This seems to suggest that the cold-climate plasticulture system, typically an annual production system, is not ideal for perennial production, but would be popular as an annual system.The conventional matted row system, most commonly used in colder production regions, was the least popular system in the first year and was ranked between the advanced matted row
'/>"/>

Contact: Michael W. Neff
mwneff@ashs.org
703-836-4606
American Society for Horticultural Science  
Source:Eurekalert

Page: 1 2

Related biology news :

1. CU-Boulder team discovers first ancient manioc fields in Americas

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Strawberry fields ripe for the picking
Strawberry fields ripe for the picking
(Date:11/23/2009)...of General Medical Sciences (NIGMS), part of the N...42.3 million for grants in scientific areas it ide...ed the GO grant program to stimulate biomedical re... American Recovery and Reinvestment Act (Recovery ...e to have a significant impact on a field of biome...
(Date:11/23/2009)...aled how environmental irritants such as air pollu... research published today in the American Journal...uthors of the study, from Imperial College London ...action inside the lungs that can trigger coughing ...n the air. They suggest that their findings may ul...
(Date:11/23/2009)...asty business, posing dangers to human health and ...s launching a new project with funding from the U....ets the fat and grease that contribute to millions...ners new tools to further reduce the risk of sewag...y" sewer systems, as opposed to "combined" systems...
Breaking Biology News(10 mins):NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research reveals exactly how coughing is triggered by environmental irritants 2Lose the fat: Targeting grease to curtail sewer overflows 2Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 1Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 2Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 3Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 4Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 5Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 6Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 7CSC to Kick Off National Blood Drive Campaign July 8 at Global Headquarters in Virginia 50743 1CSC to Kick Off National Blood Drive Campaign July 8 at Global Headquarters in Virginia 50743 2Smart for Life 28TM 29 Introduces HeroFiber 28TM 29 to Its Product Line 50740 1Smart for Life 28TM 29 Introduces HeroFiber 28TM 29 to Its Product Line 50740 2
...n human stem cell research, producing embryonic-li...ly speed up the development of treatments for life... The discovery made during a project undertaken wi...anch and the Synthecon Corporation in the United S...with an ethical and reliable source of human stem ...
...e US could soon be asked to approve a human trial ...brid of the HIV and Ebola viruses. Tests on monkey...s far more efficiently than any other method devel...iller viruses sounds horrifying, the risks should ...to develop an effective form of gene therapy to tr...
...sed on a recently published article in Environment...teria and a newly discovered group of marine worms...h uses sunken marine mammals as its sole source of...tal Microbiology, Dr Shana Goffredi and her collea...ia and the Osedax (bone-devouring) group of marine...
Other Biology News:Researchers propose measures to curb lion attacks in Tanzania 2Can two killers make a cure? 2
(Date:11/23/2009)..., LANSING,Mich.,Nov.23/PRNewswire-FirstCall/-...tRichardT.Crowder,Ph.D.,waselectedtoNeogen,sBoardo...holders. ,, Crowderhasmorethan40yearsofexperien...ntlyservesasanadjunctprofessorofagriculturaleconom...y2007,heservedasUnitedStateschiefagriculturenegoti...
(Date:11/23/2009)..., MOUNTAINVIEW,Calif.,Nov.23/PRNewswire/--Fro...dhealthcarecompaniesfordemonstratingleadershipandi...HealthcareInnovationAwardsBanquetheldinSanAntonio,.../prnh/20081117/FSLOGO ) ,, TheHealthcareInnovat...ntcontributiontothedeliveryandmanagementofhealthca...
(Date:11/20/2009)... Spain and Latin American countries have an opport...sectors. Researchers from the University of Valenc...ion, have studied the productive fabric of the Spa...hat Spain,s food and plant sectors have more clout...technology as applied to food and plants has been ...
(Date:11/20/2009)..., , STOCKHOLM, November 20 /PRNewswi...hat the European Investment Fund (EIF) has entered...The co-investment fund will be,managed by Karolins...,portfolio of early-stage pharmaceutical and medic...26.7 M Euros in the co-investment fund. The agreem...
Breaking Biology Technology:Richard T. Crowder Joins Neogen's Board of Directors 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Spanish biotechnology should focus on food and plant sectors to be more competitive 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3
...eutics,Inc. (Nasdaq: FOLD ), a biopharmaceutical ...red pharmacological chaperones for the treatment o... results from its recently,completed Phase 2 clini...),for Fabry disease. As of November 2007, Amigal i...Genetic Therapies (HGT), a business unit of,Shire ...
...lved; Remaining Issues Pertain to cGMP Com...mpany Expects to Resolve cGMP Issues in the Next S...,Pharmaceuticals, Inc. (Nasdaq: IDEV ) today anno... from the U.S. Food and Drug Administration (FDA) ...uring and controls (CMC) NDA,supplement submitted ...
... Inc. enters into an exclusive, distribution agree...d New Zealand -, LA...Technologies &,Bioressources Inc. ("Neptune") (NAS...it has entered into an exclusive distribution agre...ional") for Australia and New,Zealand. AZPA Intern...
Other Biology Technology:Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 2Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 3Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 4Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 5Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease 6Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM) 2Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM) 3Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM) 4Nationwide product launch of NKO(R) planned for February 2008 in Australia and New Zealand 2Nationwide product launch of NKO(R) planned for February 2008 in Australia and New Zealand 3
Permeabilization Solution, 5X from CHEMICON
Cytofix/Cytoperm Kit from BD Biosciences Pharmingen
Cytofix/Cytoperm Plus Kit with GolgiPlug from BD Biosciences Pharmingen
MasterAmp Taq PCR Core Kit from EPICENTRE Biotechnologies
Biology Products: